Furthermore, the incubation of CD16-overexpressing NK92 (NK92-CD16) cells and MM.1S-luc cells also showed significantly improved lytic ability of NK92-CD16 cells against tumor cells in the presence of BK1 (Figure 2C). This evidence concerns the gene FCGR3A and neoplasm.